about
MHC class I cross-talk with CD2 and CD28 induces specific intracellular signalling and leads to growth retardation and apoptosis via a p56(lck)-dependent mechanismAnti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials.Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response.Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.Low prevalence of oral and nasal human papillomavirus in employees performing CO2-laser evaporation of genital warts or loop electrode excision procedure of cervical dysplasia.Dendritic cells in peripheral tolerance and immunity.Airway Inflammation in Chronic Rhinosinusitis with Nasal Polyps and Asthma: The United Airways Concept Further Supported.CTLA-4 blockade during dendritic cell based booster vaccination influences dendritic cell survival and CTL expansion.Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy.Induction of Bcl-xL-specific cytotoxic T lymphocytes in mice.Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial.Tolerogenic dendritic cells pulsed with enterobacterial extract suppress development of colitis in the severe combined immunodeficiency transfer model.Changes in protein expression in p53 deleted spontaneous thymic lymphomas.Glycan-mediated modification of the immune response.Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial.Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate.Dexamethasone/1alpha-25-dihydroxyvitamin D3-treated dendritic cells suppress colitis in the SCID T-cell transfer model.Induction of regulatory dendritic cells by dexamethasone and 1alpha,25-Dihydroxyvitamin D(3).Addition of TAT protein transduction domain and GrpE to human p53 provides soluble fusion proteins that can be transduced into dendritic cells and elicit p53-specific T-cell responses in HLA-A*0201 transgenic mice.Genome-wide gene expression profiling of SCID mice with T-cell-mediated Colitis.Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination.Blockage of the neurokinin 1 receptor and capsaicin-induced ablation of the enteric afferent nerves protect SCID mice against T-cell-induced chronic colitis.Correction: Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing.Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function.Demonstration of strong enterobacterial reactivity of CD4+CD25- T cells from conventional and germ-free mice which is counter-regulated by CD4+CD25+ T cells.Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.Human adipose-derived stromal cells in a clinically applicable injectable alginate hydrogel: Phenotypic and immunomodulatory evaluation.TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis.Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2.CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.Secretion, blood levels and cutaneous expression of TL1A in psoriasis patients.Auto-reactive T cells revised. Overestimation based on methodology?[Perianal condylomes and diagnosis of syphilis].Treatment of transplanted CT26 tumour with dendritic cell vaccine in combination with blockade of vascular endothelial growth factor receptor 2 and CTLA-4The effect of a therapeutic dendritic cell-based cancer vaccination depends on the blockage of CTLA-4 signalingCharacterization of Monocyte-Derived Dendritic Cells Maturated With IFN-alphaTL1A regulates TCRγδ+ intraepithelial lymphocytes and gut microbial compositionAberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicityMUC4-specific CTLsInduction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes
P50
Q22010855-FA7D5654-9BB9-4CD4-A454-282FA9C37B26Q34405616-257CEEAB-8EA7-461F-B35E-CEED34AACC12Q34494018-8522DF38-60A5-4F22-9350-02145CD66CC0Q34988382-4ECDEAD5-4DD2-495C-9B25-1B01D55F03B8Q35190371-2F8DB13F-997E-49A8-9500-08AD97A1CF03Q35219314-13CCDD11-3F14-4B57-9193-962D0AED5D64Q35680199-295209C1-4732-4936-8C07-BB0BF1607F15Q35945339-645368EC-FE99-41E9-A464-CF2C43A7F7F1Q38142315-261A12D1-B554-4BCC-B5E9-5451A8516E7CQ38993215-396B8761-6A0B-4BC4-A8FF-B7409C5FE0AAQ39941863-06B8D1F5-94AE-4D37-8AEB-23D47AEFE81BQ40224289-44DD8FEF-EABA-46F6-94FB-6186BF1C91BBQ40572110-5C50664A-8FF7-48FD-8177-D78FE650A6ACQ40725344-4EF17BFF-64A0-492E-AE37-1F1F1B43E97FQ43080246-F41296FE-84F1-453A-A573-EE7ED73FD326Q43252637-CA74AA38-5ADE-4660-940A-3A5DDF987AF8Q43824130-95C4C02C-2D8D-4D3F-8EC1-CAA37CA82366Q44752238-C772A5AC-8358-4745-9E3C-3110D1721440Q44960269-020403D4-6AA2-4E44-ADD0-D50D753F1A4EQ45227029-0D2BDA45-F4C6-471C-9946-ECF42EE74571Q45245826-57BF7BD6-F9A4-44F2-9722-3F60E1F6D113Q46072127-A8F4F36B-D074-49E3-A609-51E980FF3EF0Q47125395-A63CC3C6-D273-4EDD-9A22-7F5C6A2DA7A6Q47841318-CB34BE2C-0125-4A78-A66D-6AE0D9B6D29CQ48020872-C36019A7-ED47-4ED9-9245-49B7B5568EB1Q48032969-368F4F41-9775-4BA5-9044-80303D9800B4Q49045997-532CD2EE-4291-40A4-BDA3-8CA9E1D15816Q50977622-0C1E32C6-5D86-4C5F-81BB-604D987836B5Q50977622-34CF49D7-7545-49BF-ADE1-41BBE4513C7FQ51963389-F5513F7D-650A-49C0-B0F8-9E31D77DA38AQ53242824-451927B4-B1B6-46DB-BBC9-D8DC66546859Q53531912-F80E813E-9F36-40F6-8E02-9DEF69C817A8Q54271291-1800B630-6EFC-45A4-89F7-A1CC462FFC49Q54326466-BE51804D-17B4-4D53-86D1-71EC0DCF973BQ56902239-0A5F5B54-6014-4317-BC0F-10E5234C9B32Q56902415-AA0C9A86-F609-489A-AD5A-6AC245812E80Q56999847-D145A8F4-6502-485B-BE7B-EE05C5C7153CQ57107770-0297700E-B6EE-4E67-A7AF-0FB42FE1E9ABQ57195301-DD13111C-B0D8-4351-9B96-567E9810711DQ57195305-0371DA63-BFCB-41B9-9C64-118B908723E9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anders Elm Pedersen
@ast
Anders Elm Pedersen
@en
Anders Elm Pedersen
@es
Anders Elm Pedersen
@nl
type
label
Anders Elm Pedersen
@ast
Anders Elm Pedersen
@en
Anders Elm Pedersen
@es
Anders Elm Pedersen
@nl
prefLabel
Anders Elm Pedersen
@ast
Anders Elm Pedersen
@en
Anders Elm Pedersen
@es
Anders Elm Pedersen
@nl
P106
P21
P31
P496
0000-0003-4705-1801